secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2025-04-18T23:59:59+00:00
Accession:  0001664710-25-000038
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros Therapeutics agrees with Pontifax on director slate & standstill through 2025
--------------------------------------------------------------------------------

- Agreement nominates Mary Ann Gray, Ran Nussbaum, and Alpna Seth for election at 2025 annual meeting.
- Pontifax agrees to standstill until earlier of Dec 31, 2025 or 30 days before 2026 annual meeting deadline.
- Parties agree to mutual non-disparagement obligations until the sunset date.
- Letter agreement filed as Exhibit 10.1; resolves potential activist governance conflict.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000038/0001664710-25-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000038/kros-20250417.htm
  HTML page:      https://secwatch.observer/filing/0001664710-25-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer